These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 18834413)

  • 1. Imaging angiogenesis and the microenvironment.
    Fukumura D; Jain RK
    APMIS; 2008; 116(7-8):695-715. PubMed ID: 18834413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor microvasculature and microenvironment: novel insights through intravital imaging in pre-clinical models.
    Fukumura D; Duda DG; Munn LL; Jain RK
    Microcirculation; 2010 Apr; 17(3):206-25. PubMed ID: 20374484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization.
    Fukumura D; Jain RK
    Microvasc Res; 2007; 74(2-3):72-84. PubMed ID: 17560615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize.
    Fukumura D; Jain RK
    J Cell Biochem; 2007 Jul; 101(4):937-49. PubMed ID: 17171643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into the regulation of tumor dormancy by angiogenesis in experimental tumors.
    Indraccolo S
    Adv Exp Med Biol; 2013; 734():37-52. PubMed ID: 23143974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normalization of the vasculature for treatment of cancer and other diseases.
    Goel S; Duda DG; Xu L; Munn LL; Boucher Y; Fukumura D; Jain RK
    Physiol Rev; 2011 Jul; 91(3):1071-121. PubMed ID: 21742796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo characterization of tumor and tumor vascular network using multi-modal imaging approach.
    Kalchenko V; Madar-Balakirski N; Meglinski I; Harmelin A
    J Biophotonics; 2011 Sep; 4(9):645-9. PubMed ID: 21714099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapy.
    Gee MS; Procopio WN; Makonnen S; Feldman MD; Yeilding NM; Lee WM
    Am J Pathol; 2003 Jan; 162(1):183-93. PubMed ID: 12507901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vessel abnormalization: another hallmark of cancer? Molecular mechanisms and therapeutic implications.
    De Bock K; Cauwenberghs S; Carmeliet P
    Curr Opin Genet Dev; 2011 Feb; 21(1):73-9. PubMed ID: 21106363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinctive features of angiogenesis and lymphangiogenesis determine their functionality during de novo tumor development.
    Eichten A; Hyun WC; Coussens LM
    Cancer Res; 2007 Jun; 67(11):5211-20. PubMed ID: 17545601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving delivery of antineoplastic agents with anti-vascular endothelial growth factor therapy.
    Yang AD; Bauer TW; Camp ER; Somcio R; Liu W; Fan F; Ellis LM
    Cancer; 2005 Apr; 103(8):1561-70. PubMed ID: 15754332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules.
    Dvorak HF; Nagy JA; Dvorak JT; Dvorak AM
    Am J Pathol; 1988 Oct; 133(1):95-109. PubMed ID: 2459969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-course-dependent microvascular alterations in a model of myeloid leukemia in vivo.
    Schaefer C; Krause M; Fuhrhop I; Schroeder M; Algenstaedt P; Fiedler W; Rüther W; Hansen-Algenstaedt N
    Leukemia; 2008 Jan; 22(1):59-65. PubMed ID: 17898789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-color fluorescence imaging distinguishes tumor cells from induced host angiogenic vessels and stromal cells.
    Yang M; Li L; Jiang P; Moossa AR; Penman S; Hoffman RM
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14259-62. PubMed ID: 14614130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor vasculature and microenvironment normalization: a possible mechanism of antiangiogenesis therapy.
    Huang G; Chen L
    Cancer Biother Radiopharm; 2008 Oct; 23(5):661-7. PubMed ID: 18986217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy.
    Brown EB; Campbell RB; Tsuzuki Y; Xu L; Carmeliet P; Fukumura D; Jain RK
    Nat Med; 2001 Jul; 7(7):864-8. PubMed ID: 11433354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms associated with tumor vascular shut-down induced by combretastatin A-4 phosphate: intravital microscopy and measurement of vascular permeability.
    Tozer GM; Prise VE; Wilson J; Cemazar M; Shan S; Dewhirst MW; Barber PR; Vojnovic B; Chaplin DJ
    Cancer Res; 2001 Sep; 61(17):6413-22. PubMed ID: 11522635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study of tumor blood perfusion and its variation due to vascular normalization by anti-angiogenic therapy based on 3D angiogenic microvasculature.
    Wu J; Long Q; Xu S; Padhani AR
    J Biomech; 2009 Apr; 42(6):712-21. PubMed ID: 19268290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges.
    Martin JD; Seano G; Jain RK
    Annu Rev Physiol; 2019 Feb; 81():505-534. PubMed ID: 30742782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normalization of the tumor microvasculature based on targeting and modulation of the tumor microenvironment.
    Li Z; Ning F; Wang C; Yu H; Ma Q; Sun Y
    Nanoscale; 2021 Oct; 13(41):17254-17271. PubMed ID: 34651623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.